Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 25.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Offi |
| 16.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Office |
Stammdaten
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Unternehmen & Branche
| Name | Neuraxis, INC |
|---|---|
| Ticker | NRXS |
| CIK | 0001933567 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 3845 · Electromedical & Electrotherapeutic Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 85,8 Mio. USD |
| Beta | 1,89 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 3,569,282 | -7,800,555 | -0.95 | 6,404,036 | 3,399,372 |
| 2025-09-30 | 10-Q | 811,414 | -2,122,796 | -0.24 | 5,776,363 | 2,284,941 |
| 2025-06-30 | 10-Q | 894,086 | -1,690,418 | -0.22 | 7,087,999 | 4,253,294 |
| 2025-03-31 | 10-Q | 895,655 | -2,278,684 | -0.33 | 3,029,809 | 258,479 |
| 2024-12-31 | 10-K | 2,685,925 | -8,241,501 | -1.22 | 4,757,572 | 2,067,748 |
| 2024-09-30 | 10-Q | 666,625 | -1,755,234 | -0.25 | 1,143,269 | -1,793,932 |
| 2024-06-30 | 10-Q | 611,500 | -2,917,710 | -0.42 | 2,633,338 | -5,258,382 |
| 2024-03-31 | 10-Q | 646,635 | -2,120,651 | -0.32 | 945,729 | -3,184,454 |
| 2023-12-31 | 10-K | 2,460,049 | -14,626,683 | -4.50 | 509,498 | -1,403,241 |
| 2023-09-30 | 10-K | 477,460 | -8,625,363 | 1,235,918 | -1,061,087 | |
| 2023-09-30 | 10-Q | 477,460 | -8,625,363 | -2.38 | 1,235,918 | -1,061,087 |
| 2023-06-30 | 10-Q | 646,021 | -2,235,614 | -1.21 | 1,539,691 | -9,982,635 |
| 2023-03-31 | 10-Q | 805,110 | -2,173,408 | -1.18 | -7,747,021 | |
| 2022-12-31 | 10-K | 2,684,735 | -4,780,061 | -2.77 | 1,480,644 | -5,573,613 |
| 2022-09-30 | 10-Q | 618,805 | -2,079,682 | -1.14 | -5,561,409 | |
| 2022-06-30 | 10-Q | 682,581 | -1,516,530 | -0.87 | -3,487,242 | |
| 2022-03-31 | 10-Q | -1,170,221 | -1,983,887 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Henrichs Timothy Robert | Officer, Chief Financial Officer | Open Market Purchase | 7,593 | 1.96 | 14,882.28 | +3,3% | |
| 2026-04-01 | Carrico Thomas Joeseph | Officer, CRO, CCO, CPO | Open Market Purchase | 667 | 1.96 | 1,307.32 | +0,3% | |
| 2026-04-01 | Carrico Brian Allen | Director, Officer, Chief Executive Officer | Open Market Purchase | 8,060 | 1.96 | 15,797.60 | +3,5% | |
| 2026-02-12 | Hannasch Brian | 10% Owner | Open Market Purchase | 40,000 | 4.92 | 196,800.00 | +43,5% | |
| 2026-02-11 | Hannasch Brian | 10% Owner | Open Market Purchase | 40,000 | 4.65 | 186,000.00 | +41,1% | |
| 2025-12-23 | Aharon Gil | Director | Open Market Purchase | 286,138 | 3.52 | 1,007,205.76 | +222,7% | |
| 2025-07-01 | Hannasch Brian | 10% Owner | Open Market Purchase | 355,556 | 2.25 | 800,001.00 | +176,9% | |
| 2025-07-01 | MASIMO CORP | 10% Owner | Open Market Sale | -531,548 | 2.25 | -1,195,983.00 | -264,5% | |
| 2025-07-01 | MASIMO CORP | 10% Owner | Open Market Sale | -289,779 | 2.25 | -652,002.75 | -144,2% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.